Possible role of S-equol on bone loss via amelioration of inflammatory indices in ovariectomized mice

  • Nishide Yoriko
    Department of Food Function and Labeling, National Institute of Health and Nutrition Cooperative Major in Advanced Health Science, Tokyo University of Agriculture and Technology
  • Tadaishi Miki
    Department of Food Function and Labeling, National Institute of Health and Nutrition
  • Kobori Masuko
    National Food Research Institute, National Agriculture and Food Research Organization
  • Tousen Yuko
    Department of Food Function and Labeling, National Institute of Health and Nutrition
  • Kato Michiko
    Department of Food Function and Labeling, National Institute of Health and Nutrition
  • Inada Masaki
    Cooperative Major in Advanced Health Science, Tokyo University of Agriculture and Technology
  • Miyaura Chisato
    Cooperative Major in Advanced Health Science, Tokyo University of Agriculture and Technology
  • Ishimi Yoshiko
    Department of Food Function and Labeling, National Institute of Health and Nutrition

書誌事項

タイトル別名
  • Possible role of <i>S</i>-equol on bone loss via amelioration of inflammatory indices in ovariectomized mice

この論文をさがす

抄録

S-equol is a natural metabolite of the soy isoflavone, daidzein, produced by intestinal bacteria. S-equol has been shown to have greater estrogenic activity than other soy isoflavones and prevent bone loss in post-menopausal women. Estrogen regulates both bone remodeling and hemopoiesis in the bone marrow, these processes that communicate closely with each other. In this study, we investigated the effect of S-equol on bone mass and gene expression of bone marrow cells in ovariectomized (OVX) mice. Female ddY strain mice, aged 12 weeks, were either sham operated or OVX. The OVX mice were randomly divided into two groups: (1) OVX control and (2) OVX fed a 0.06% (w/w) S-equol supplemented diet. After 2 weeks, the trabecular bone volume of the femoral distal metaphysis was markedly reduced in OVX mice. However, treatment with equol was observed to ameliorate this. Expression of inflammatory-, osteoclastogenesis- and adipogenesis-related genes was increased in OVX mice compared with sham mice, and equol was observed to suppress their expression. The present study demonstrates that equol might ameliorate bone loss caused by estrogen deficiency through regulating hemopoiesis and production of inflammatory cytokines in bone marrow cells.

収録刊行物

被引用文献 (7)*注記

もっと見る

参考文献 (49)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ